InvestorsHub Logo
Followers 1
Posts 1178
Boards Moderated 0
Alias Born 02/01/2013

Re: None

Thursday, 05/11/2017 9:52:58 AM

Thursday, May 11, 2017 9:52:58 AM

Post# of 108192
Dan said during interview WuxiApptec,In addition, we have seen strong data suggesting how our lead product candidate, axalimogene filolisbac, will work well with Merck’s KEYTRUDA® and AstraZeneca’s duvalumab.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News